{"id":"NCT03290378","sponsor":"Avenue Therapeutics, Inc.","briefTitle":"Tramadol Versus Placebo in the Management of Postoperative Pain Following Bunionectomy","officialTitle":"A Phase 3, Multicenter, Randomized, Double Blind, Three-Arm Study to Evaluate the Efficacy and Safety of Tramadol Infusion (AVE-901) Versus Placebo in the Management of Postoperative Pain Following Bunionectomy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-09-19","primaryCompletion":"2018-04-11","completion":"2018-04-23","firstPosted":"2017-09-21","resultsPosted":"2020-03-19","lastUpdate":"2020-03-19"},"enrollment":409,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Pain Management"],"interventions":[{"type":"DRUG","name":"Tramadol","otherNames":[]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"AVE-901 50 mg","type":"ACTIVE_COMPARATOR"},{"label":"AVE-901 25 mg","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The study evaluates the effectiveness and safety of IV tramadol compared to placebo managing postoperative pain following a bunionectomy","primaryOutcome":{"measure":"The Sum of Pain Intensity Differences (SPID) Through 48 Hours Post First Dose","timeFrame":"48 hours post first dose","effectByArm":[{"arm":"AVE-901 50 mg","deltaMin":-122.8,"sd":null},{"arm":"AVE-901 25 mg","deltaMin":-110.9,"sd":null},{"arm":"Placebo","deltaMin":-97.8,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"<.005"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":14},"locations":{"siteCount":5,"countries":["United States"]},"refs":{"pmids":["32683644"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":140},"commonTop":["Nausea","Vomiting","Headache","Dizziness","Infusion Site Pain"]}}